Industry reports
Editor highlights

Publication dates

Chemotherapy Research Reports, April 2014

You might be interested in: flow cytometry, hematology, cancer, more »


 

1-10 of 80 reports for Chemotherapy
Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

Infusion Pumps & Accessories Market by Product (Volumetric, Syringe, Enteral, Insulin, Implantable, PCA Pump), Application (Diabetes, Chemotherapy, Nutrition, Pain Management) & by End-user (Hospital, Home Healthcare) - Global Forecasts to 2018

  • $ 4 650
  • Industry report
  • April 2014
  • by MarketsandMarkets

... Infusion pumps & accessories market by product (volumetric, syringe, enteral, insulin, implantable, pca pump), application (diabetes, chemotherapy, nutrition, pain management) & by end-user (hospital ...

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on chemotherapy induced pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary ...

Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review

Heron Therapeutics, Inc. (HRTX) - Financial and Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • March 2014
  • by Global Data

... Is being developed to prevent chemotherapy-induced nausea and vomiting, or emesis in the treatment of cancer patients. Other development programs include expansion of the labeled indication for sustol ...

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Briefing pertaining to the number of trials for the key drugs for treating chemotherapy induced peripheral neuropathy. This report is built using data and information sourced from proprietary databases ...

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Neutropenia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Information and data relating to the clinical trials on chemotherapy induced neutropenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across ...

Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Anemia Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... To the clinical trials on chemotherapy induced anemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...

Insys Therapeutics, Inc. (INSY) - Financial and Strategic SWOT Analysis Review

Insys Therapeutics, Inc. (INSY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • March 2014
  • by Global Data

... To marinol (dronabinol), which is an approved second-line treatment of chemotherapy-induced nausea and vomiting (cinv), and anorexia related to weight loss in patients with aids.Insys therapeutics, inc ...

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global Clinical Trials Review, H1, 2014

Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • March 2014
  • by Global Data

... Of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating chemotherapy induced acral erythema (hand-foot syndrome). This report is built using data and information ...

Global Radiation Therapy Equipment Market 2014-2018

Global Radiation Therapy Equipment Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

... And chemotherapy.Technavio's analysts forecast the global radiation therapy equipment market will grow at a cagr of 6.04 Percent over the period 2013-2018.Covered in this reportthe global ...

Kadmon Corporation, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Kadmon Corporation, LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • February 2014
  • by Global Data

... To reduce gi and other chemotherapy associated toxicities; kd019 is a tyrosine inhibitor; and kd032 is a ras antagonist, which inhibits overactive cell growth in cancer. It provides antibodies such as anti ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.